BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23274863)

  • 21. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
    Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
    Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
    [No Abstract]   [Full Text] [Related]  

  • 22. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 23. Rescue trans-radial renal denervation with the new Symplicity Spyral™ catheter.
    Greco F; Spagnolo V; Fascetti F
    Minerva Cardioangiol; 2015 Dec; 63(6):587-8. PubMed ID: 26657534
    [No Abstract]   [Full Text] [Related]  

  • 24. [Catheter-based renal sympathetic denervation for treatment of hypertension].
    Kimura G; Fukuta H
    Nihon Naika Gakkai Zasshi; 2011 Feb; 100(2):441-5. PubMed ID: 21400883
    [No Abstract]   [Full Text] [Related]  

  • 25. Transcatheter renal sympathetic ablation for resistant hypertension: in vivo insights in humans from optical coherence tomography.
    Ierna S; Biondi-Zoccai G; Bachis C; Occhipinti M; Di Vito L; Ricciardi A; Pappone C; Prati F
    Int J Cardiol; 2013 May; 165(2):e35-7. PubMed ID: 23164587
    [No Abstract]   [Full Text] [Related]  

  • 26. Follow-up, study design and outcome parameters.
    Volpe M; Battistoni A; Tocci G
    EuroIntervention; 2013 May; 9 Suppl R():R96-100. PubMed ID: 23732163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistant hypertension: the role of interventional therapy.
    Aursulesei V
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):127-36. PubMed ID: 24505904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement].
    Witkowski A; Januszewicz A; Imiela J; Narkiewicz K; Opolski G; Rowiński O; Sadowski J; Dudek D; Bryniarski L; Gil RJ; Adamczak M; Grajek S; Kądziela J; Prejbisz A; Nowicki M
    Kardiol Pol; 2011; 69(11):1208-11. PubMed ID: 22090243
    [No Abstract]   [Full Text] [Related]  

  • 29. The temperature field simulation of radiofrequency catheter-based renal sympathetic denervation for resistant hypertension.
    Guo X; Zhai F; Nan Q
    Biomed Mater Eng; 2014; 24(1):315-21. PubMed ID: 24211912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients: more questions than answers.
    Dimitriadis K; Tsioufis C; Tousoulis D
    Int J Cardiol; 2014 Oct; 176(3):1382. PubMed ID: 25147074
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?
    Mahfoud F; Lenski M; Böhm M
    Future Cardiol; 2011 Sep; 7(5):591-4. PubMed ID: 21929337
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?
    Katholi RE; Rocha-Singh KJ
    Prog Cardiovasc Dis; 2009; 52(3):243-8. PubMed ID: 19917336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endovascular renal artery denervation: why, when, and how?
    Sapoval M; Azizi M; Bobrie G; Cholley B; Pagny JY; Plouin PF
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):463-71. PubMed ID: 22314774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal denervation to treat resistant hypertension: Guarded optimism.
    Thomas G; Shishehbor MH; Bravo EL; Nally JV
    Cleve Clin J Med; 2012 Jul; 79(7):501-10. PubMed ID: 22751635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal sympathetic denervation for resistant hypertension in a patient with a single kidney.
    Xu B; Whitbourn RJ
    Med J Aust; 2014 Mar; 200(4):206-7. PubMed ID: 24580520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Renal sympathetic denervation (RSD): a new, non-pharmacologic therapeutic strategy for treatment-resistant hypertension (TRH). Report of the first procedure in Mexico].
    Gaspar Hernández J; Eid-Lidt G; Payró Ramírez G; Ricalde Alcocer A; Martínez Ríos MA
    Gac Med Mex; 2012; 148(2):125-9. PubMed ID: 22622311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The complexity after simplicity: how to proceed with renal denervation in hypertension?
    Blankestijn PJ; Alings M; Voskuil M; Grobbee DE
    Eur J Prev Cardiol; 2015 Apr; 22(4):412-4. PubMed ID: 24914028
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal failure after renal sympathetic ablation in a patient with chronic kidney disease--which came first, the chicken or the egg?
    Schneider S; Baumann M; Lefeldt S; Laugwitz KL; Heemann U
    Int J Cardiol; 2013 Sep; 167(6):e177-8. PubMed ID: 23647587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.